Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet‐induced obese rats. (24th November 2014)
- Record Type:
- Journal Article
- Title:
- Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet‐induced obese rats. (24th November 2014)
- Main Title:
- Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet‐induced obese rats
- Authors:
- Müller‐Fielitz, Helge
Lau, Margot
Geißler, Cathleen
Werner, Lars
Winkler, Martina
Raasch, Walter - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bph12949-sec-0001" sec-type="section"> <title>Background and Purpose</title> <p>AT<sub>1</sub> receptor blockers (ARBs) represent an approach for treating metabolic syndrome due to their potency in reducing hypertension, body weight and onset of type 2 diabetes. The mechanism underlying ARB‐induced weight loss is still unclear.</p> </sec> <sec id="bph12949-sec-0002" sec-type="section"> <title>Experimental Approach</title> <p>Leptin resistance tests (LRTs) in diet‐induced obese or lean rats were conducted to determine whether telmisartan (8 mg·kg<sup>−1</sup>·day<sup>−1</sup>, 14 days) enhances leptin sensitivity. Phosphorylation of signal transducer and activator of transcription 3 (pSTAT3) staining was performed in hypothalami to determine leptin transport across the blood–brain barrier.</p> </sec> <sec id="bph12949-sec-0003" sec-type="section"> <title>Key Results</title> <p>Telmisartin reduced weight gain, food intake and plasma leptin but blood pressure remained unchanged. The 24 h profiles of plasma leptin after saline injections were similar in controls and telmisartan‐treated rats, but after leptin injections were higher in controls and slightly lower in telmisartan‐treated animals. After telmisartan, energy intake during LRT was lower in leptin‐ than in saline‐pretreated rats, but remained unchanged in controls, irrespectively of whether rats received saline or leptin.<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bph12949-sec-0001" sec-type="section"> <title>Background and Purpose</title> <p>AT<sub>1</sub> receptor blockers (ARBs) represent an approach for treating metabolic syndrome due to their potency in reducing hypertension, body weight and onset of type 2 diabetes. The mechanism underlying ARB‐induced weight loss is still unclear.</p> </sec> <sec id="bph12949-sec-0002" sec-type="section"> <title>Experimental Approach</title> <p>Leptin resistance tests (LRTs) in diet‐induced obese or lean rats were conducted to determine whether telmisartan (8 mg·kg<sup>−1</sup>·day<sup>−1</sup>, 14 days) enhances leptin sensitivity. Phosphorylation of signal transducer and activator of transcription 3 (pSTAT3) staining was performed in hypothalami to determine leptin transport across the blood–brain barrier.</p> </sec> <sec id="bph12949-sec-0003" sec-type="section"> <title>Key Results</title> <p>Telmisartin reduced weight gain, food intake and plasma leptin but blood pressure remained unchanged. The 24 h profiles of plasma leptin after saline injections were similar in controls and telmisartan‐treated rats, but after leptin injections were higher in controls and slightly lower in telmisartan‐treated animals. After telmisartan, energy intake during LRT was lower in leptin‐ than in saline‐pretreated rats, but remained unchanged in controls, irrespectively of whether rats received saline or leptin. Leptin minimized the gain in body weight during LRT in telmisartan‐treated rats as compared with saline‐treated animals. pSTAT3 staining was reduced in cafeteria diet‐fed rats as compared with chow‐fed rats but this was normalized by telmisartan. Telmisartin reduced hypothalamic mRNA levels of the orexigenic peptides melanin‐concentrating hormone and prepro‐orexin.</p> </sec> <sec id="bph12949-sec-0004" sec-type="section"> <title>Conclusions and Implications</title> <p>Rats fed a cafeteria diet develop leptin resistance after 2 weeks. Leptin sensitivity was preserved by telmisartan treatment even in rats fed a cafeteria diet. This pleiotropic effect is not related to the hypotensive action of telmisartan.</p> </sec> </abstract> … (more)
- Is Part Of:
- British journal of pharmacology. Volume 172:Number 3(2015:Feb.)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 172:Number 3(2015:Feb.)
- Issue Display:
- Volume 172, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 172
- Issue:
- 3
- Issue Sort Value:
- 2015-0172-0003-0000
- Page Start:
- 857
- Page End:
- 868
- Publication Date:
- 2014-11-24
- Subjects:
- Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.12949 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3970.xml